home All News open_in_new Full Article
Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer’s Disease
today 17 h. ago attach_file Economics
attach_file
Economics
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Events
attach_file
Sport
attach_file
Economics
attach_file
Economics
attach_file
Economics
attach_file
Economics
3 w. ago
Predictmedix AI Announces Closing of $320,000 First Tranche to Accelerate Commercialization
attach_file
Economics
attach_file
Other
attach_file
Economics
attach_file
Other
ID: 3593978095